Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2013

01-02-2013 | Review Article

Nodular lesions and mesangiolysis in diabetic nephropathy

Authors: Takashi Wada, Miho Shimizu, Hitoshi Yokoyama, Yasunori Iwata, Yoshio Sakai, Shuichi Kaneko, Kengo Furuichi

Published in: Clinical and Experimental Nephrology | Issue 1/2013

Login to get access

Abstract

Diabetic nephropathy is a leading cause of end-stage renal failure all over the world. Advanced human diabetic nephropathy is characterized by the presence of specific lesions including nodular lesions, doughnut lesions, and exudative lesions. Thus far, animal models precisely mimicking advanced human diabetic nephropathy, especially nodular lesions, remain to be fully established. Animal models with spontaneous diabetic kidney diseases or with inducible kidney lesions may be useful for investigating the pathogenesis of diabetic nephropathy. Based on pathological features, we previously reported that diabetic glomerular nodular-like lesions were formed during the reconstruction process of mesangiolysis. Recently, we established nodular-like lesions resembling those seen in advanced human diabetic nephropathy through vascular endothelial injury and mesangiolysis by administration of monocrotaline. Here, in this review, we discuss diabetic nodular lesions and its animal models resembling human diabetic kidney lesions, with our hypothesis that endothelial cell injury and mesangiolysis might be required for nodular lesions.
Literature
1.
go back to reference Parving HH, Mauer M, Fioretto P, Rossing P, Ritz E. Diabetic nephropathy. In: Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu ASL, Brenner BM, editors. The Kidney. Philadelphia: Elsevier Saunders; 2012. p. 1411–54. Parving HH, Mauer M, Fioretto P, Rossing P, Ritz E. Diabetic nephropathy. In: Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu ASL, Brenner BM, editors. The Kidney. Philadelphia: Elsevier Saunders; 2012. p. 1411–54.
2.
go back to reference Wada T, Shimizu M, Toyama T, Hara A, Kaneko S, Furuichi K. Clinical impact of albuminuria in diabetic nephropathy. Clin Exp Nephrol. 2012;16:96–101.PubMedCrossRef Wada T, Shimizu M, Toyama T, Hara A, Kaneko S, Furuichi K. Clinical impact of albuminuria in diabetic nephropathy. Clin Exp Nephrol. 2012;16:96–101.PubMedCrossRef
3.
go back to reference Moriya T, Moriya R, Yajima Y, Steffes MW, Mauer M. Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients. Nephron. 2002;91:292–9.PubMedCrossRef Moriya T, Moriya R, Yajima Y, Steffes MW, Mauer M. Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients. Nephron. 2002;91:292–9.PubMedCrossRef
4.
go back to reference Osterby R, Gall MA, Schmitz A, Nielsen FS, Nyberg G, Parving HH. Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993;36:1064–70.PubMedCrossRef Osterby R, Gall MA, Schmitz A, Nielsen FS, Nyberg G, Parving HH. Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993;36:1064–70.PubMedCrossRef
5.
go back to reference Ritz E, Wolf G. Pathogenesis, clinical manifestations, and natural history of diabetic nephropathy. In: Floege J, Johnson RJ, Feehally J, editors. Comprehensive clinical nephrology. Philadelphia: Elsevier Saunders; 2010. p. 359–76.CrossRef Ritz E, Wolf G. Pathogenesis, clinical manifestations, and natural history of diabetic nephropathy. In: Floege J, Johnson RJ, Feehally J, editors. Comprehensive clinical nephrology. Philadelphia: Elsevier Saunders; 2010. p. 359–76.CrossRef
6.
go back to reference Kimmelstiel P, Wilson C. Intercapillary lesions in the glomeruli of kidney. Am J Pathol. 1936;12:83–98.PubMed Kimmelstiel P, Wilson C. Intercapillary lesions in the glomeruli of kidney. Am J Pathol. 1936;12:83–98.PubMed
7.
go back to reference Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, Breyer MD, Harris RC. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol. 2006;17:2664–9.PubMedCrossRef Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, Breyer MD, Harris RC. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol. 2006;17:2664–9.PubMedCrossRef
8.
go back to reference Yu L, Su Y, Paueksakon P, Cheng H, Chen X, Wang H, Harris RC, Zent R, Pozzi A. Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy. Kidney Int. 2012;81:1086–97.PubMedCrossRef Yu L, Su Y, Paueksakon P, Cheng H, Chen X, Wang H, Harris RC, Zent R, Pozzi A. Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy. Kidney Int. 2012;81:1086–97.PubMedCrossRef
9.
go back to reference Watanabe M, Nakashima H, Miyake K, Sato T, Saito T. Aggravation of diabetic nephropathy in OLETF rats by Thy-1.1 nephritis. Clin Exp Nephrol. 2011;15:25–9.PubMedCrossRef Watanabe M, Nakashima H, Miyake K, Sato T, Saito T. Aggravation of diabetic nephropathy in OLETF rats by Thy-1.1 nephritis. Clin Exp Nephrol. 2011;15:25–9.PubMedCrossRef
10.
go back to reference Ainsworth SK, Hirsch HZ, Brackett NC Jr, Brissie RM, Williams AV Jr, Hennigar GR. Diabetic glomerulonephropathy: histopathologic, immunofluorescent, and ultrastructural studies of 16 cases. Hum Pathol. 1982;13:470–8.PubMedCrossRef Ainsworth SK, Hirsch HZ, Brackett NC Jr, Brissie RM, Williams AV Jr, Hennigar GR. Diabetic glomerulonephropathy: histopathologic, immunofluorescent, and ultrastructural studies of 16 cases. Hum Pathol. 1982;13:470–8.PubMedCrossRef
11.
go back to reference Glick AD, Jacobson HR, Haralson MA. Mesangial deposition of type I collagen in human glomerulosclerosis. Hum Pathol. 1992;23:1373–9.PubMedCrossRef Glick AD, Jacobson HR, Haralson MA. Mesangial deposition of type I collagen in human glomerulosclerosis. Hum Pathol. 1992;23:1373–9.PubMedCrossRef
12.
go back to reference Nishi S, Ueno M, Hisaki S, Iino N, Iguchi S, Oyama Y, Imai N, Arakawa M, Gejyo F. Ultrastructural characteristics of diabetic nephropathy. Med Electron Microsc. 2000;33:65–73.PubMedCrossRef Nishi S, Ueno M, Hisaki S, Iino N, Iguchi S, Oyama Y, Imai N, Arakawa M, Gejyo F. Ultrastructural characteristics of diabetic nephropathy. Med Electron Microsc. 2000;33:65–73.PubMedCrossRef
13.
go back to reference Saito Y, Kida H, Takeda S, Yoshimura M, Yokoyama H, Koshino Y, Hattori N. Mesangiolysis in diabetic glomeruli: its role in the formation of nodular lesions. Kidney Int. 1988;34:389–96.PubMedCrossRef Saito Y, Kida H, Takeda S, Yoshimura M, Yokoyama H, Koshino Y, Hattori N. Mesangiolysis in diabetic glomeruli: its role in the formation of nodular lesions. Kidney Int. 1988;34:389–96.PubMedCrossRef
14.
go back to reference Ikeda K, Kida H, Yokoyama H, Naito T, Takasawa K, Goshima S, Takeda S, Yoshimura M, Tomosugi N, Abe T, Hattori N, Oshima A. Participation of collagen fibers in morphogenesis of diabetic nodular lesions. Jpn J Nephrol. 1988;7:843–53. Ikeda K, Kida H, Yokoyama H, Naito T, Takasawa K, Goshima S, Takeda S, Yoshimura M, Tomosugi N, Abe T, Hattori N, Oshima A. Participation of collagen fibers in morphogenesis of diabetic nodular lesions. Jpn J Nephrol. 1988;7:843–53.
15.
go back to reference Hong D, Zheng T, Jia-qing S, Jian W, Zhi-hong L, Lei-shi L. Nodular glomerular lesion: a later stage of diabetic nephropathy? Diabetes Res Clin Pract. 2007;78:189–95.PubMedCrossRef Hong D, Zheng T, Jia-qing S, Jian W, Zhi-hong L, Lei-shi L. Nodular glomerular lesion: a later stage of diabetic nephropathy? Diabetes Res Clin Pract. 2007;78:189–95.PubMedCrossRef
16.
go back to reference Schwartz MM, Lewis EJ, Leonard-Martin T, Lewis JB, Batlle D. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transpl. 1998;13:2547–52.CrossRef Schwartz MM, Lewis EJ, Leonard-Martin T, Lewis JB, Batlle D. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transpl. 1998;13:2547–52.CrossRef
17.
go back to reference Sanai T, Okuda S, Yoshimitsu T, Oochi N, Kumagai H, Katafuchi R, Harada A, Chihara J, Abe T, Nakamoto M, Hirakata H, Onoyama K, Iida M. Nodular glomerulosclerosis in patients without any manifestation of diabetes mellitus. Nephrology (Carlton). 2007;12:69–73.CrossRef Sanai T, Okuda S, Yoshimitsu T, Oochi N, Kumagai H, Katafuchi R, Harada A, Chihara J, Abe T, Nakamoto M, Hirakata H, Onoyama K, Iida M. Nodular glomerulosclerosis in patients without any manifestation of diabetes mellitus. Nephrology (Carlton). 2007;12:69–73.CrossRef
18.
go back to reference Bazari H, Guimaraes AR, Kushner YB. Case 20-2012: a 77-year-old man with leg edema, hematuria, and acute renal failure. N Engl J Med. 2012;366:2503–15.PubMedCrossRef Bazari H, Guimaraes AR, Kushner YB. Case 20-2012: a 77-year-old man with leg edema, hematuria, and acute renal failure. N Engl J Med. 2012;366:2503–15.PubMedCrossRef
19.
go back to reference Furuichi K, Hisada Y, Shimizu M, Kitagawa K, Yoshimoto K, Iwata Y, Yokoyama H, Kaneko S, Wada T. Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats. Nephrol Dial Transpl. 2011;26:3124–31.CrossRef Furuichi K, Hisada Y, Shimizu M, Kitagawa K, Yoshimoto K, Iwata Y, Yokoyama H, Kaneko S, Wada T. Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats. Nephrol Dial Transpl. 2011;26:3124–31.CrossRef
20.
go back to reference Brosius FC 3rd, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, Gurley SB, Harris RC, Kakoki M, Kretzler M, Leiter EH, Levi M, McIndoe RA, Sharma K, Smithies O, Susztak K, Takahashi N, Takahashi T, Animal Models of Diabetic Complications Consortium. Mouse models of diabetic nephropathy. J Am Soc Nephrol. 2009;20:2503–12.PubMedCrossRef Brosius FC 3rd, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, Gurley SB, Harris RC, Kakoki M, Kretzler M, Leiter EH, Levi M, McIndoe RA, Sharma K, Smithies O, Susztak K, Takahashi N, Takahashi T, Animal Models of Diabetic Complications Consortium. Mouse models of diabetic nephropathy. J Am Soc Nephrol. 2009;20:2503–12.PubMedCrossRef
21.
go back to reference Inagi R, Yamamoto Y, Nangaku M, Usuda N, Okamato H, Kurokawa K, van Ypersele de Strihou C, Yamamoto H, Miyata T. A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice. Diabetes. 2006;55:356–66.PubMedCrossRef Inagi R, Yamamoto Y, Nangaku M, Usuda N, Okamato H, Kurokawa K, van Ypersele de Strihou C, Yamamoto H, Miyata T. A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice. Diabetes. 2006;55:356–66.PubMedCrossRef
22.
go back to reference Kida H, Yoshimura M, Ikeda K, Saitou Y, Noto Y. Pathogenesis of diabetic nephropathy in non-insulin-dependent diabetes mellitus. J Diabetes Complicat. 1991;5:82–3.CrossRef Kida H, Yoshimura M, Ikeda K, Saitou Y, Noto Y. Pathogenesis of diabetic nephropathy in non-insulin-dependent diabetes mellitus. J Diabetes Complicat. 1991;5:82–3.CrossRef
23.
go back to reference Mohan S, Reddick RL, Musi N, Horn DA, Yan B, Prihoda TJ, Natarajan M, Abboud-Werner SL. Diabetic eNOS knockout mice develop distinct macro- and microvascular complications. Lab Invest. 2008;88:515–28.PubMedCrossRef Mohan S, Reddick RL, Musi N, Horn DA, Yan B, Prihoda TJ, Natarajan M, Abboud-Werner SL. Diabetic eNOS knockout mice develop distinct macro- and microvascular complications. Lab Invest. 2008;88:515–28.PubMedCrossRef
24.
go back to reference Kanetsuna Y, Takahashi K, Nagata M, Gannon MA, Breyer MD, Harris RC, Takahashi T. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol. 2007;170:1473–84.PubMedCrossRef Kanetsuna Y, Takahashi K, Nagata M, Gannon MA, Breyer MD, Harris RC, Takahashi T. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol. 2007;170:1473–84.PubMedCrossRef
25.
go back to reference Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol. 2007;18:539–50.PubMedCrossRef Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol. 2007;18:539–50.PubMedCrossRef
26.
go back to reference Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, Ogawa D, Kido Y, Nagase R, Yozai K, Ohga S, Tone A, Wada J, Takeya M, Horiuchi S, Kodama T, Makino H. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation. Diabetes. 2007;56:363–72.PubMedCrossRef Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, Ogawa D, Kido Y, Nagase R, Yozai K, Ohga S, Tone A, Wada J, Takeya M, Horiuchi S, Kodama T, Makino H. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation. Diabetes. 2007;56:363–72.PubMedCrossRef
27.
go back to reference Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, Takeda S, Takasawa K, Yoshimura M, Kida H, Kobayashi K, Mukaida N, Naito T, Matsushima K, Yokoyama H. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions in human diabetic nephropathy. Kidney Int. 2000;58:1492–9.PubMedCrossRef Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, Takeda S, Takasawa K, Yoshimura M, Kida H, Kobayashi K, Mukaida N, Naito T, Matsushima K, Yokoyama H. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions in human diabetic nephropathy. Kidney Int. 2000;58:1492–9.PubMedCrossRef
28.
go back to reference Sakai N, Wada T, Furuichi K, Iwata Y, Yoshimoto K, Kitagawa K, Kokubo S, Kobayashi M, Hara A, Yamahana J, Okumura T, Takasawa K, Takeda S, Yoshimura M, Kida H, Yokoyama H. Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis. 2005;45:54–65.PubMedCrossRef Sakai N, Wada T, Furuichi K, Iwata Y, Yoshimoto K, Kitagawa K, Kokubo S, Kobayashi M, Hara A, Yamahana J, Okumura T, Takasawa K, Takeda S, Yoshimura M, Kida H, Yokoyama H. Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis. 2005;45:54–65.PubMedCrossRef
29.
go back to reference Wada T, Yokoyama H, Furuichi K, Kobayashi K, Harada K, Naruto M, Su S, Akiyama M, Mukaida N, Matsushima K. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J. 1996;10:1418–25.PubMed Wada T, Yokoyama H, Furuichi K, Kobayashi K, Harada K, Naruto M, Su S, Akiyama M, Mukaida N, Matsushima K. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J. 1996;10:1418–25.PubMed
30.
go back to reference Wada T, Sakai N, Sakai Y, Matsushima K, Kaneko S, Furuichi K. Involvement of bone-marrow-derived cells in kidney fibrosis. Clin Exp Nephrol. 2011;15:8–13.PubMedCrossRef Wada T, Sakai N, Sakai Y, Matsushima K, Kaneko S, Furuichi K. Involvement of bone-marrow-derived cells in kidney fibrosis. Clin Exp Nephrol. 2011;15:8–13.PubMedCrossRef
31.
go back to reference Wada T, Sakai N, Matsushima K, Kaneko S. Fibrocytes: a new insight into kidney fibrosis. Kidney Int. 2007;72:269–73.PubMedCrossRef Wada T, Sakai N, Matsushima K, Kaneko S. Fibrocytes: a new insight into kidney fibrosis. Kidney Int. 2007;72:269–73.PubMedCrossRef
32.
go back to reference Sakai N, Furuichi K, Shinozaki Y, Yamauchi H, Toyama T, Kitajima S, Okumura T, Kokubo S, Kobayashi M, Takasawa K, Takeda S, Yoshimura M, Kaneko S, Wada T. Fibrocytes are involved in the pathogenesis of human chronic kidney disease. Hum Pathol. 2010;41:672–8.PubMedCrossRef Sakai N, Furuichi K, Shinozaki Y, Yamauchi H, Toyama T, Kitajima S, Okumura T, Kokubo S, Kobayashi M, Takasawa K, Takeda S, Yoshimura M, Kaneko S, Wada T. Fibrocytes are involved in the pathogenesis of human chronic kidney disease. Hum Pathol. 2010;41:672–8.PubMedCrossRef
33.
go back to reference Makino H, Shikata K, Kushiro M, Hironaka K, Yamasaki Y, Sugimoto H, Ota Z, Araki N, Horiuchi S. Roles of advanced glycation end-products in the progression of diabetic nephropathy. Nephrol Dial Transpl. 1996;11(Suppl 5):76–80.CrossRef Makino H, Shikata K, Kushiro M, Hironaka K, Yamasaki Y, Sugimoto H, Ota Z, Araki N, Horiuchi S. Roles of advanced glycation end-products in the progression of diabetic nephropathy. Nephrol Dial Transpl. 1996;11(Suppl 5):76–80.CrossRef
34.
go back to reference Nadarajah R, Milagres R, Dilauro M, Gutsol A, Xiao F, Zimpelmann J, Kennedy C, Wysocki J, Batlle D, Burns KD. Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice. Kidney Int. 2012;82:292–303.PubMedCrossRef Nadarajah R, Milagres R, Dilauro M, Gutsol A, Xiao F, Zimpelmann J, Kennedy C, Wysocki J, Batlle D, Burns KD. Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice. Kidney Int. 2012;82:292–303.PubMedCrossRef
35.
go back to reference Flaquer M, Franquesa M, Vidal A, Bolaños N, Torras J, Lloberas N, Herrero-Fresneda I, Grinyó JM, Cruzado JM. Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia. 2012;55:2059–68.PubMedCrossRef Flaquer M, Franquesa M, Vidal A, Bolaños N, Torras J, Lloberas N, Herrero-Fresneda I, Grinyó JM, Cruzado JM. Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia. 2012;55:2059–68.PubMedCrossRef
36.
go back to reference Miyamoto S, Shikata K, Miyasaka K, Okada S, Sasaki M, Kodera R, Hirota D, Kajitani N, Takatsuka T, Kataoka HU, Nishishita S, Sato C, Funakoshi A, Nishimori H, Uchida HA, Ogawa D, Makino H. Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin. Diabetes. 2012;61:897–907.PubMedCrossRef Miyamoto S, Shikata K, Miyasaka K, Okada S, Sasaki M, Kodera R, Hirota D, Kajitani N, Takatsuka T, Kataoka HU, Nishishita S, Sato C, Funakoshi A, Nishimori H, Uchida HA, Ogawa D, Makino H. Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin. Diabetes. 2012;61:897–907.PubMedCrossRef
Metadata
Title
Nodular lesions and mesangiolysis in diabetic nephropathy
Authors
Takashi Wada
Miho Shimizu
Hitoshi Yokoyama
Yasunori Iwata
Yoshio Sakai
Shuichi Kaneko
Kengo Furuichi
Publication date
01-02-2013
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2013
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-012-0711-6

Other articles of this Issue 1/2013

Clinical and Experimental Nephrology 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.